Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Dolutegravir And Rilpivirine (J05Ar21) Within The Framework Of A So-Called Open-House Model.

AOK RHEINLAND-PFALZ SAARLAND - DIE GESUNDHEITSKASSE Germany has Released a tender for Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Dolutegravir And Rilpivirine (J05Ar21) Within The Framework Of A So-Called Open-House Model. in Food and Beverages. The tender was released on Jun 12, 2024.

Country - Germany

Summary - Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Dolutegravir And Rilpivirine (J05Ar21) Within The Framework Of A So-Called Open-House Model.

Deadline - May 31, 2026

GT reference number - 82861993

Product classification - Food, beverages, tobacco and related products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 82861993

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Dolutegravir And Rilpivirine (J05Ar21) Within The Framework Of A So-Call ed Open-House Model.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Dolutegravir und Rilpivirin (J05AR21) im Rahmen eines sogenannten Open-House-Modells.type_of_procedure: Otherbidding_response_method: Not Available

Gt Ref Id - 82861993

Deadline - May 31, 2026

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database